Found: 19
Select item for more details and to access through your institution.
Kinetics of the hepatitis B core‐related antigen and treatment responses in chronic hepatitis B patients treated with tenofovir alafenamide.
- Published in:
- Hepatology Research, 2024, v. 54, n. 11, p. 993, doi. 10.1111/hepr.14052
- By:
- Publication type:
- Article
Shorter pruritus period and milder disease stage are associated with response to nalfurafine hydrochloride in patients with chronic liver disease.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-11431-1
- By:
- Publication type:
- Article
Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter Study.
- Published in:
- Infectious Diseases & Therapy, 2021, v. 10, n. 1, p. 269, doi. 10.1007/s40121-020-00364-9
- By:
- Publication type:
- Article
Discrepancy between Hepatitis C Virus Genotypes and NS4-Based Serotypes: Association with Their Subgenomic Sequences.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 1, p. 172, doi. 10.3390/ijms18010172
- By:
- Publication type:
- Article
Japanese patient preferences regarding intermediate to advanced hepatocellular carcinoma treatments.
- Published in:
- Patient Preference & Adherence, 2019, v. 13, p. 637, doi. 10.2147/PPA.S198363
- By:
- Publication type:
- Article
Efficacy of direct‐acting antiviral treatment in patients with compensated liver cirrhosis: A multicenter study.
- Published in:
- Hepatology Research, 2019, v. 49, n. 2, p. 125, doi. 10.1111/hepr.13256
- By:
- Publication type:
- Article
Efficacy and safety of ombitasvir/paritaprevir/ritonavir combination therapy for genotype 1b chronic hepatitis C patients complicated with chronic kidney disease.
- Published in:
- Hepatology Research, 2018, v. 48, n. 7, p. 549, doi. 10.1111/hepr.13058
- By:
- Publication type:
- Article
Efficacy and safety of ombitasvir/paritaprevir/ritonavir in dialysis patients with genotype 1b chronic hepatitis C.
- Published in:
- Hepatology Research, 2017, v. 47, n. 13, p. 1429, doi. 10.1111/hepr.12910
- By:
- Publication type:
- Article
Comparison of six hepatocellular carcinoma prediction models in Japanese patients after sustained virologic response undergoing rigorous surveillance for hepatocellular carcinoma.
- Published in:
- Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 5, p. 949, doi. 10.1111/jgh.16494
- By:
- Publication type:
- Article
Response to peginterferon-alfa 2b and ribavirin in Japanese patients with chronic hepatitis C genotype 2.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Successful Eradication of Hepatitis C Virus by Interferon-Free Regimens in Two Patients with Advanced Liver Fibrosis following Kidney Transplantation.
- Published in:
- Case Reports in Gastroenterology, 2016, v. 10, n. 2, p. 248, doi. 10.1159/000445374
- By:
- Publication type:
- Article
Occurrence of Hepatocellular Carcinoma Was Not a Rare Event during and Immediately after Antiviral Treatment in Japanese HCV-Positive Patients.
- Published in:
- Oncology, 2011, v. 80, n. 5/6, p. 366, doi. 10.1159/000330549
- By:
- Publication type:
- Article
International multicenter validation of GES score for HCC risk stratification in chronic hepatitis C patients.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 9, p. 807, doi. 10.1111/jvh.13717
- By:
- Publication type:
- Article
Sequential therapy from entecavir to tenofovir alafenamide versus continuous entecavir monotherapy for patients with chronic hepatitis B.
- Published in:
- JGH Open, 2021, v. 5, n. 1, p. 34, doi. 10.1002/jgh3.12443
- By:
- Publication type:
- Article
Marked heterogeneity in the diagnosis of compensated cirrhosis of patients with chronic hepatitis C virus infection in a real‐world setting: A large, multicenter study from Japan.
- Published in:
- Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 8, p. 1420, doi. 10.1111/jgh.14982
- By:
- Publication type:
- Article
Real‐world experience of 12‐week direct‐acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection.
- Published in:
- Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 5, p. 855, doi. 10.1111/jgh.14874
- By:
- Publication type:
- Article
Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter study.
- Published in:
- Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 2, p. 364, doi. 10.1111/jgh.14447
- By:
- Publication type:
- Article
Sustained virologic response achieved after curative treatment of hepatitis C virus-related hepatocellular carcinoma as an independent prognostic factor.
- Published in:
- Journal of Gastroenterology & Hepatology, 2015, v. 30, n. 7, p. 1197, doi. 10.1111/jgh.12925
- By:
- Publication type:
- Article
IFNL4 ss469415590 Variant Is Associated with Treatment Response in Japanese HCV Genotype 1 Infected Individuals Treated with IFN-Including Regimens.
- Published in:
- International Journal of Hepatology, 2014, p. 1, doi. 10.1155/2014/723868
- By:
- Publication type:
- Article